ERNA vs UAL · P/E 0.0, rev $582.0K vs P/E 10, rev $57.06B
Eterna Therapeutics Inc (ERNA) versus United Airlines Holdings Inc (UAL) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
United Airlines Holdings Inc (UAL) is a airlines company listed on NASDAQ. It is led by Scott Kirby.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported UAL revenue for 2024-12-31 was $57.06B. Net income was $3.15B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. UAL currently screens at market cap $37.59B and trailing P/E 10.4.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. UAL currently screens at market cap $37.59B and trailing P/E 10.4.
Not investment advice. Open the ERNA and UAL stock pages for the full models.
Not investment advice.